141 related articles for article (PubMed ID: 7496837)
21. Mammographically detected breast cancers and the risk of axillary lymph node involvement: is it just the tumor size?
Heimann R; Munsell M; McBride R
Cancer J; 2002; 8(3):276-81. PubMed ID: 12074328
[TBL] [Abstract][Full Text] [Related]
22. Routine Axillary Ultrasound for Patients with T1-T2 Breast Cancer Does Not Increase the Rate of Axillary Lymph Node Dissection Based on Predictive Modeling.
Wellington J; Sanders T; Mylander C; Alden A; Harris C; Buras R; Tafra L; Liang W; Stelle L; Rosman M; Jackson RS
Ann Surg Oncol; 2018 Aug; 25(8):2271-2278. PubMed ID: 29868976
[TBL] [Abstract][Full Text] [Related]
23. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
[TBL] [Abstract][Full Text] [Related]
24. [Axillary lymph node metastases in breast cancer. Anatomo-clinical correlation and surgical approach].
Coroş MF; Stolnicu S; Georgescu R; Roşca A; Sorlea S; Dobre A; Podeanu D; Pălăsan A; Man C; Turcan C
Chirurgia (Bucur); 2009; 104(5):557-64. PubMed ID: 19943554
[TBL] [Abstract][Full Text] [Related]
25. Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients.
Pamilo M; Soiva M; Lavast EM
J Ultrasound Med; 1989 Mar; 8(3):115-20. PubMed ID: 2657088
[TBL] [Abstract][Full Text] [Related]
26. Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast.
Margolis DS; McMillen MA; Hashmi H; Wasson DW; MacArthur JD
Surg Gynecol Obstet; 1992 Feb; 174(2):109-13. PubMed ID: 1734568
[TBL] [Abstract][Full Text] [Related]
27. Axillary lymph nodes: mammographic, pathologic, and clinical correlation.
Walsh R; Kornguth PJ; Soo MS; Bentley R; DeLong DM
AJR Am J Roentgenol; 1997 Jan; 168(1):33-8. PubMed ID: 8976915
[TBL] [Abstract][Full Text] [Related]
28. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
29. Frequency and Predictors of Axillary Lymph Node Metastases in Iranian Women with Early Breast Cancer.
Sandoughdaran S; Malekzadeh M; Mohammad Esmaeil ME
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1617-1620. PubMed ID: 29936787
[TBL] [Abstract][Full Text] [Related]
30. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
[TBL] [Abstract][Full Text] [Related]
31. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
32. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound and fine needle aspiration cytology of axillary lymph nodes in breast cancer. To do or not to do?
Leenders MW; Broeders M; Croese C; Richir MC; Go HL; Langenhorst BL; Meijer S; Schreurs WH
Breast; 2012 Aug; 21(4):578-83. PubMed ID: 22717665
[TBL] [Abstract][Full Text] [Related]
34. Nonimage-guided fine needle aspiration biopsy of palpable axillary lymph nodes in breast cancer patients.
Marti JL; Ayo D; Levine P; Hernandez O; Rescigno J; Axelrod DM
Breast J; 2012; 18(1):3-7. PubMed ID: 22098412
[TBL] [Abstract][Full Text] [Related]
35. Predicting axillary nodal positivity in 2282 patients with breast carcinoma.
Silverstein MJ; Skinner KA; Lomis TJ
World J Surg; 2001 Jun; 25(6):767-72. PubMed ID: 11376414
[TBL] [Abstract][Full Text] [Related]
36. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
37. Axillary lymph node dissection in pT1 breast cancer: a retrospective analysis of 315 patients and review of the literature.
Witt A; Obwegeser R; Auerbach L; Tempfer C; Yavuz D; Kubista E
Wien Klin Wochenschr; 2002 Jun; 114(10-11):387-90. PubMed ID: 12708092
[TBL] [Abstract][Full Text] [Related]
38. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
39. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
[TBL] [Abstract][Full Text] [Related]
40. Treatment of the axilla in patients with screen-detected breast cancer.
Walls J; Boggis CR; Wilson M; Asbury DL; Roberts JV; Bundred NJ; Mansel RE
Br J Surg; 1993 Apr; 80(4):436-8. PubMed ID: 8495303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]